-Reuters Citing Ukrainian Officials
Related Posts
Is This A Miracle Drug For ‘Sticky Cholesterol’? Analysts Applaud Safety, Efficacy Of Silence Therapeutics’ Heart Disease Candidate
Earlier today, Silence Therapeutics plc (NASDAQ: SLN) announced topline results from the multiple-dose component of the APOLLO phase 1 study of zerlasiran (formerly SLN360) in 36 adults with baseline lipoprotein(a) (Lp(a), levels at or over 150 nmol/L and stable atherosclerotic
Dow Jumps Over 100 Points; Eli Lilly Posts Upbeat Earnings
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Tuesday.
Following the market opening Tuesday, the Dow traded up 0.34% to 38,509.84 while the NASDAQ rose 0.21% to 15,629.82. The S&P 500 also rose, gaining, 0.17% to 4,951.38.
Investor Sentiment Increases Ahead Of Jobs Report, Dow Jumps Over 300 Points
The CNN Money Fear and Greed index showed further improvement in the overall market sentiment, but the index…